Tag: RampD
Amgen Drops Eczema Drug Pact As Investors Weigh R&D Focus And Valuation – simplywall.st
eczemarelief
February 4, 2026
Amgen Lawsuit And Eczema Drug Exit Reframe Risk And R&D Priorities – simplywall.st
eczemarelief
January 31, 2026
Eczema Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution – The Globe and Mail
eczemarelief
November 22, 2025